Gurcan Gunaydin, MD, PhD

Gurcan completed his MD/PhD at Hacettepe University Cancer Institute in Ankara, Turkey, where he studied the interplay between the complex tumor microenvironment (TME) of breast cancer on the adaptive anti-tumor immune response. In the Freed-Pastor laboratory, Gurcan is leading efforts to accelerate effective TCR engineered T cells for pancreas cancer.